Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica
Background: Ultraviolet A1 (340-400 nm) was found to be effective in the treatment of cutaneous T-cell-mediated diseases. Objective: The purpose of the present study was to assess the efficacy of UVA1 phototherapy for pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis lichenoides c...
Gespeichert in:
| Veröffentlicht in: | Journal of the American Academy of Dermatology 2002-09, Vol.47 (3), p.410-414 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 414 |
|---|---|
| container_issue | 3 |
| container_start_page | 410 |
| container_title | Journal of the American Academy of Dermatology |
| container_volume | 47 |
| creator | Pinton, Piergiacomo Calzavara Capezzera, Rossana Zane, Cristina De Panfilis, Giuseppe |
| description | Background: Ultraviolet A1 (340-400 nm) was found to be effective in the treatment of cutaneous T-cell-mediated diseases. Objective: The purpose of the present study was to assess the efficacy of UVA1 phototherapy for pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis lichenoides chronica (PLC). Methods: Eight patients (3 with PLEVA and 5 with PLC) received 60 J/cm2 UVA1 daily until remission. Four patients also had lesions inaccessible to UVA1 that were used as control lesions. Immunocytologic studies of skin infiltrates and circulating T cells were done. Results: Six patients showed complete clinical and histologic recovery. Two patients with PLC had a partial improvement. Unirradiated control lesions never improved. Serious short-term adverse effects were not encountered. No effects on circulating lymphocytes were reported. Conclusion: UVA1 therapy is an effective and well-tolerated treatment for PLEVA and PLC. The therapeutic activity seems to be related to direct effects on cutaneous inflammatory infiltrates because the lesions in nonexposed cutaneous areas did not respond. (J Am Acad Dermatol 2002;47:410-4.) |
| doi_str_mv | 10.1067/mjd.2002.122199 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72034075</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962202001287</els_id><sourcerecordid>72034075</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-b67116c9c8d8515434479906475c8b8975212b6c196c81d7f0d6e5c31c4d06653</originalsourceid><addsrcrecordid>eNp10TtPwzAUBWALgaA8ZjaUBbYU20n8GBHiJYFYYLbc6xvVKImLnVT03-OqlZiYPPg7V9fHhFwyOmdUyNv-y805pXzOOGdaH5AZo1qWQip5SGaUaVpqwfkJOU3pi1Kq60oekxOWsZANm5GfN3R-6ksXEhZTN0a79qHDsbhjxbjEaFebog2xWPlxE71NPhWdhyUOwTtMRYZrG3PCZ9TnSwvTaAs7uP8SsIxh8GDPyVFru4QX-_OMfD4-fNw_l6_vTy_3d68lVLIay4WQjAnQoJxqWFNXdS21pqKWDaiF0rLhjC8E5PeAYk621AlsoGJQOypEU52Rm93cVQzfE6bR5DUBu84OGKZkJKdVTeUW3u4gxJBSxNasou9t3BhGzbZsk8s227LNruycuNqPnhY9uj-_bzeD6z2wCWzXRjuAT3-uUkpxpbLTO4e5iLXHaBJ4HCB_TUQYjQv-3yV-ATjdnAg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72034075</pqid></control><display><type>article</type><title>Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Pinton, Piergiacomo Calzavara ; Capezzera, Rossana ; Zane, Cristina ; De Panfilis, Giuseppe</creator><creatorcontrib>Pinton, Piergiacomo Calzavara ; Capezzera, Rossana ; Zane, Cristina ; De Panfilis, Giuseppe</creatorcontrib><description>Background: Ultraviolet A1 (340-400 nm) was found to be effective in the treatment of cutaneous T-cell-mediated diseases. Objective: The purpose of the present study was to assess the efficacy of UVA1 phototherapy for pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis lichenoides chronica (PLC). Methods: Eight patients (3 with PLEVA and 5 with PLC) received 60 J/cm2 UVA1 daily until remission. Four patients also had lesions inaccessible to UVA1 that were used as control lesions. Immunocytologic studies of skin infiltrates and circulating T cells were done. Results: Six patients showed complete clinical and histologic recovery. Two patients with PLC had a partial improvement. Unirradiated control lesions never improved. Serious short-term adverse effects were not encountered. No effects on circulating lymphocytes were reported. Conclusion: UVA1 therapy is an effective and well-tolerated treatment for PLEVA and PLC. The therapeutic activity seems to be related to direct effects on cutaneous inflammatory infiltrates because the lesions in nonexposed cutaneous areas did not respond. (J Am Acad Dermatol 2002;47:410-4.)</description><identifier>ISSN: 0190-9622</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1067/mjd.2002.122199</identifier><identifier>PMID: 12196751</identifier><identifier>CODEN: JAADDB</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adult ; Biological and medical sciences ; Diseases of the skin. Cosmetics ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; Pityriasis Lichenoides - pathology ; Pityriasis Lichenoides - radiotherapy ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Ultraviolet Therapy - methods</subject><ispartof>Journal of the American Academy of Dermatology, 2002-09, Vol.47 (3), p.410-414</ispartof><rights>2002 American Academy of Dermatology, Inc</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-b67116c9c8d8515434479906475c8b8975212b6c196c81d7f0d6e5c31c4d06653</citedby><cites>FETCH-LOGICAL-c373t-b67116c9c8d8515434479906475c8b8975212b6c196c81d7f0d6e5c31c4d06653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1067/mjd.2002.122199$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13888288$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12196751$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pinton, Piergiacomo Calzavara</creatorcontrib><creatorcontrib>Capezzera, Rossana</creatorcontrib><creatorcontrib>Zane, Cristina</creatorcontrib><creatorcontrib>De Panfilis, Giuseppe</creatorcontrib><title>Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><description>Background: Ultraviolet A1 (340-400 nm) was found to be effective in the treatment of cutaneous T-cell-mediated diseases. Objective: The purpose of the present study was to assess the efficacy of UVA1 phototherapy for pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis lichenoides chronica (PLC). Methods: Eight patients (3 with PLEVA and 5 with PLC) received 60 J/cm2 UVA1 daily until remission. Four patients also had lesions inaccessible to UVA1 that were used as control lesions. Immunocytologic studies of skin infiltrates and circulating T cells were done. Results: Six patients showed complete clinical and histologic recovery. Two patients with PLC had a partial improvement. Unirradiated control lesions never improved. Serious short-term adverse effects were not encountered. No effects on circulating lymphocytes were reported. Conclusion: UVA1 therapy is an effective and well-tolerated treatment for PLEVA and PLC. The therapeutic activity seems to be related to direct effects on cutaneous inflammatory infiltrates because the lesions in nonexposed cutaneous areas did not respond. (J Am Acad Dermatol 2002;47:410-4.)</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Diseases of the skin. Cosmetics</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pityriasis Lichenoides - pathology</subject><subject>Pityriasis Lichenoides - radiotherapy</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Ultraviolet Therapy - methods</subject><issn>0190-9622</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10TtPwzAUBWALgaA8ZjaUBbYU20n8GBHiJYFYYLbc6xvVKImLnVT03-OqlZiYPPg7V9fHhFwyOmdUyNv-y805pXzOOGdaH5AZo1qWQip5SGaUaVpqwfkJOU3pi1Kq60oekxOWsZANm5GfN3R-6ksXEhZTN0a79qHDsbhjxbjEaFebog2xWPlxE71NPhWdhyUOwTtMRYZrG3PCZ9TnSwvTaAs7uP8SsIxh8GDPyVFru4QX-_OMfD4-fNw_l6_vTy_3d68lVLIay4WQjAnQoJxqWFNXdS21pqKWDaiF0rLhjC8E5PeAYk621AlsoGJQOypEU52Rm93cVQzfE6bR5DUBu84OGKZkJKdVTeUW3u4gxJBSxNasou9t3BhGzbZsk8s227LNruycuNqPnhY9uj-_bzeD6z2wCWzXRjuAT3-uUkpxpbLTO4e5iLXHaBJ4HCB_TUQYjQv-3yV-ATjdnAg</recordid><startdate>20020901</startdate><enddate>20020901</enddate><creator>Pinton, Piergiacomo Calzavara</creator><creator>Capezzera, Rossana</creator><creator>Zane, Cristina</creator><creator>De Panfilis, Giuseppe</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020901</creationdate><title>Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica</title><author>Pinton, Piergiacomo Calzavara ; Capezzera, Rossana ; Zane, Cristina ; De Panfilis, Giuseppe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-b67116c9c8d8515434479906475c8b8975212b6c196c81d7f0d6e5c31c4d06653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Diseases of the skin. Cosmetics</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pityriasis Lichenoides - pathology</topic><topic>Pityriasis Lichenoides - radiotherapy</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Ultraviolet Therapy - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pinton, Piergiacomo Calzavara</creatorcontrib><creatorcontrib>Capezzera, Rossana</creatorcontrib><creatorcontrib>Zane, Cristina</creatorcontrib><creatorcontrib>De Panfilis, Giuseppe</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pinton, Piergiacomo Calzavara</au><au>Capezzera, Rossana</au><au>Zane, Cristina</au><au>De Panfilis, Giuseppe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2002-09-01</date><risdate>2002</risdate><volume>47</volume><issue>3</issue><spage>410</spage><epage>414</epage><pages>410-414</pages><issn>0190-9622</issn><eissn>1097-6787</eissn><coden>JAADDB</coden><abstract>Background: Ultraviolet A1 (340-400 nm) was found to be effective in the treatment of cutaneous T-cell-mediated diseases. Objective: The purpose of the present study was to assess the efficacy of UVA1 phototherapy for pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis lichenoides chronica (PLC). Methods: Eight patients (3 with PLEVA and 5 with PLC) received 60 J/cm2 UVA1 daily until remission. Four patients also had lesions inaccessible to UVA1 that were used as control lesions. Immunocytologic studies of skin infiltrates and circulating T cells were done. Results: Six patients showed complete clinical and histologic recovery. Two patients with PLC had a partial improvement. Unirradiated control lesions never improved. Serious short-term adverse effects were not encountered. No effects on circulating lymphocytes were reported. Conclusion: UVA1 therapy is an effective and well-tolerated treatment for PLEVA and PLC. The therapeutic activity seems to be related to direct effects on cutaneous inflammatory infiltrates because the lesions in nonexposed cutaneous areas did not respond. (J Am Acad Dermatol 2002;47:410-4.)</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>12196751</pmid><doi>10.1067/mjd.2002.122199</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0190-9622 |
| ispartof | Journal of the American Academy of Dermatology, 2002-09, Vol.47 (3), p.410-414 |
| issn | 0190-9622 1097-6787 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72034075 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adult Biological and medical sciences Diseases of the skin. Cosmetics Female Humans Male Medical sciences Middle Aged Pityriasis Lichenoides - pathology Pityriasis Lichenoides - radiotherapy Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Ultraviolet Therapy - methods |
| title | Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T14%3A42%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medium-dose%20ultraviolet%20A1%20therapy%20for%20pityriasis%20lichenoides%20et%20varioliformis%20acuta%20and%20pityriasis%20lichenoides%20chronica&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Pinton,%20Piergiacomo%20Calzavara&rft.date=2002-09-01&rft.volume=47&rft.issue=3&rft.spage=410&rft.epage=414&rft.pages=410-414&rft.issn=0190-9622&rft.eissn=1097-6787&rft.coden=JAADDB&rft_id=info:doi/10.1067/mjd.2002.122199&rft_dat=%3Cproquest_cross%3E72034075%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72034075&rft_id=info:pmid/12196751&rft_els_id=S0190962202001287&rfr_iscdi=true |